Oral Administration of OKT3 Monoclonal Antibody to Human Subjects Induces a Dose-Dependent Immunologic Effect in T Cells and Dendritic Cells-Reference-Cited by-同舟云学术

Oral Administration of OKT3 Monoclonal Antibody to Human Subjects Induces a Dose-Dependent Immunologic Effect in T Cells and Dendritic Cells

Published:2009-09-16 Issue:1 Volume:30 Page:167-177
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

Ilan Yaron,Zigmond Ehud,Lalazar Gadi,Dembinsky Adi,Ben Ya’acov Ami,Hemed Nila,Kasis Ibrahim,Axelrod Elizabeth,Zolotarov Lidya,Klein Athalia,El Haj Madi,Gandhi Roopali,Baecher-Allan Claire,Wu Henry,Murugaiyan Gopal,Kivisakk Pia,Farez Mauricio F.,Quintana Francisco J.,Khoury Samia J.,Weiner Howard L.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s10875-009-9323-7.pdf

Reference35 articles.

1. Chatenoud L, Bluestone JA. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat Rev Immunol. 2007;7:622–32.

2. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med. 2002;346:1692–8.

3. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med. 2005;352:2598–608.

4. Friend PJ, Hale G, Chatenoud L, Rebello P, Bradley J, Thiru S, et al. Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection. Transplantation. 1999;68:1632–7.

5. Ishikawa H, Ochi H, Chen ML, Frenkel D, Maron R, Weiner HL. Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody. Diabetes. 2007;56:2103–9.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating T Cell Responses by Targeting CD3;Cancers;2023-02-13

2. Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects;Frontiers in Immunology;2022-11-23

3. Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients;Frontiers in Immunology;2022-06-17

4. Oral tolerance: an updated review;Immunology Letters;2022-05

5. Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes;Expert Opinion on Investigational Drugs;2021-12-02